Nature

Cerner (CERN) Gains as the Market Falls: What You Need to Know


VSerner (CERN) closed at $93.70 last trading session, marking a +0.39% move from the previous day. The stock topped the S&P 500’s daily loss of 2.77%. Elsewhere, the Dow lost 2.82%, while the tech-heavy Nasdaq lost 0.83%.

Going into today, shares of the healthcare information technology company had lost 0.33% over the past month, lagging the 0.16% loss in the medical sector and exceeding the 1.35% loss of the S&P 500 during this period.

Cerner will be looking to show strength heading into its next earnings release. In that report, analysts expect Cerner to post earnings of $0.89 per share. This would mark a year-over-year growth of 17.11%. Meanwhile, our latest consensus estimate calls for revenue of $1.47 billion, up 5.65% from the prior year quarter.

Looking to the full year, our Zacks consensus estimates suggest analysts are expecting earnings of $3.66 per share and revenue of $6.05 billion. These totals would mark changes of +9.25% and +4.9%, respectively, from last year.

It’s also important to note recent changes to analyst estimates for Cerner. These revisions generally reflect the latest short-term trading trends, which may change frequently. Therefore, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe that these estimate revisions are directly related to the team’s close stock movements. Investors can take advantage of this by using the Zacks ranking. This model accounts for these estimation changes and provides a simple and actionable scoring system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive track record of outperformance verified by external audits, with #1 stocks generating an average annual return of +25% since 1988 Over the past 30 days, our consensus EPS projection is down 0.61%. Cerner currently sports a Zacks rank of #3 (Hold).

In terms of valuation, Cerner is currently trading at a forward P/E ratio of 25.51. This valuation marks a premium compared to the average Forward P/E of its sector of 21.41.

Additionally, it is worth mentioning that CERN has a PEG ratio of 2. This measure is used in the same way as the famous P/E ratio, but the PEG ratio also takes into account the expected growth rate of CERN’s profits. ‘stock. Medical Info Systems held an average PEG ratio of 1.52 at yesterday’s closing price.

The medical information systems industry is part of the medical sector. This group has a Zacks Industry Rank of 163, which places it in the bottom 36% of all 250+ industries.

The Zacks Industry Rankings are ranked from best to worst in terms of the average Zacks Ranking of individual companies in each of these industries. Our research shows that the top 50% of industries outperform the bottom half by a factor of 2 to 1.

Be sure to track all of these stock movement metrics, and more, at Zacks.com.

7 best stocks for the next 30 days

Just Released: Experts distill 7 elite stocks from the current Zacks No. 1 Ranking 220 Strong Buys list. They consider these tickers “most likely for early price increases.”

Since 1988, the full list has beaten the market more than 2 times with an average gain of +25.4% per year. So be sure to give your immediate attention to these 7 handpicked ones.

Discover them now >>

Click to get this free report

Cerner Corporation (CERN): Free Inventory Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


nasdaq

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button